Jump to: Page Content, Section Navigation, Site Navigation, Site Search, Account Information, or Site Tools.
Guest Alerts | Access Rights | My Account | Sign In
|
|
Sci. STKE, 7 March 2006 EDITORS' CHOICECANCER Mobilizing K-Ras to Fight Cancer
K-Ras, a small guanosine triphosphatase whose constitutive activation through mutation is associated with cancer, is targeted to the plasma membrane through a farnesylated C-terminal and a nearby polybasic region (see Feig). Noting that the polybasic region is phosphorylated by protein kinase C (PKC), a modification that could neutralize its charge and destabilize electrostatic interactions with membrane phospholipids, Bivona et al. investigated the effects of K-Ras phosphorylation on its localization. Pharmacological activation of PKC promoted the reversible translocation of green fluorescent protein (GFP)-labeled K-Ras from the plasma membrane to the endoplasmic reticulum, Golgi apparatus, and mitochondrial outer membranes. Translocation was also promoted by a construct containing the PKC T. G. Bivona, S. E. Quatela, B. O. Bodemann, I. M. Ahearn, M. J. Soskis, A. Mor, J. Miura, H. H. Wiener, L. Wright, S. G. Saba, D. Yim, A. Fein, I. Pérez de Castro, C. Li, C. B. Thompson, A. D. Cox, M. R. Philips, PKC regulates a farnesyl-electrostatic switch on K-Ras that promotes its association with Bcl-XL on mitochondria and induces apoptosis. Mol. Cell 21, 481-493 (2006). [PubMed] L. A. Feig, The odyssey of K-Ras. Mol. Cell 21, 447-449 (2006). [PubMed]
Citation: Mobilizing K-Ras to Fight Cancer. Sci. STKE 2006, tw82 (2006). The editors suggest the following Related Resources on Science sites:In Science Signaling
|
Science Signaling. ISSN 1937-9145 (pre-2008: Science's STKE. ISSN 1525-8882)